Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
247.95Prev. Close
241.50Volume
3,516Total traded value
0.08 CrUpper Circuit
289.80Lower Circuit
193.20Fundamentals
| Market Cap | ₹151Cr |
| ROE | 4.28% |
| P/E Ratio(TTM) | 215.63 |
| EPS(TTM) | 1.12 |
| P/B Ratio | 3.50 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.14 |
| Book Value | 68.94 |
| Debt to Equity | 1.05 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Auro Laboratories
Auro Laboratories Limited has been manufacturing and providing generic Active Pharmaceutical Ingredients (API) since its founding in 1992. The company is committed to operating its business in an efficient, responsible, honest, and ethical manner. It plans to increase its Metformin HCL production capacity from 1800 MTA to 3600 MTA within the current financial year.;
| Parent Organisation | Auro Laboratories Limited |
| Managing Director | Sharat Deorah |
| BSE Symbol | 530233 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 70.13 | ||
| Neuland Laboratories | NA (0.00%) | 111.47 | ||
| Jubilant Pharmova | NA (0.00%) | 37.80 | ||
| Acutaas Chemicals | NA (0.00%) | 62.78 |